SC 13G/A: Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
Published on August 5, 2009
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
13G/A
Under
the Securities Exchange Act of 1934
(Amendment
No. 2)*
Oncogenex
Pharmaceuticals, Inc.
(Name of
Issuer)
Common
Stock, $0.001 par value
(Title of
Class of Securities)
68230A
106
(CUSIP
Number)
July 31,
2009
(Date of
Event Which Requires Filing of this Statement)
Check the
appropriate box to designate the rule pursuant to which this Schedule is
filed:
o Rule
13d-1(b)
x Rule
13d-1(c)
*The
remainder of this cover page shall be filled out for a reporting person’s
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The
information required in the remainder of this cover page shall not be deemed to
be “filed” for the purpose of Section 18 of the Securities Exchange Act of
1934 (“Act”) or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
|
CUSIP No. 68230A 106
|
13G
|
Page 2
of 6
Pages
|
|
1
|
NAMES
OF REPORTING PERSONS
BDC
Capital Inc.
|
||
|
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) o
(b) o
|
||
|
3
|
SEC
USE ONLY
|
||
|
4
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
Canada
|
||
|
|
5
|
SOLE
VOTING POWER
269,854
shares
|
|
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
|
6
|
SHARED
VOTING POWER
0
shares
|
|
|
REPORTING
PERSON
WITH
|
7
|
SOLE
DISPOSITIVE POWER
269,854
shares
|
|
|
|
8
|
SHARED
DISPOSITIVE POWER
0
shares
|
|
|
9
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
269,854 shares
|
||
|
10
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE
INSTRUCTIONS) o
|
||
|
11
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW 9
4.5%
|
||
|
12
|
TYPE
OF REPORTING PERSON (SEE INSTRUCTIONS)
CO
|
||
|
CUSIP No. 68230A 106
|
13G
|
Page 3
of 6
Pages
|
Schedule 13G
|
Item
1(a).
|
Name of Issuer:
Oncogenex Pharmaceuticals, Inc.
|
|
Item
1(b).
|
Address of Issuer's
Principal Executive Offices: 1522
217th
Place S.E., Bothell, WA
98021
|
|
Item
2(a).
|
Name of Person
Filing: BDC Capital
Inc.
|
|
Item
2(b).
|
Address of Principal
Business Office or, if none, Residence: Suite 300, 5
Place Ville Marie, Montreal, Quebec, Canada H3B
5E7
|
|
Item
2(c).
|
Citizenship:
Canadian
|
|
Item
2(d).
|
Title of Class of
Securities: Common Stock, $0.001 par
value.
|
|
Item
2(e).
|
CUSIP
Number: 68230A
106
|
|
Item 3.
|
If this statement is
filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether
the person filing is a:
|
|
|
(a)
o
|
|
Broker
or Dealer registered under Section 15 of the Securities Exchange Act
of 1934 (the “Act”).
|
|
|
(b)
o
|
|
Bank
as defined in Section 3(a)(6) of the
Act.
|
|
|
(c)
o
|
|
Insurance
Company as defined in Section 3(a)(19) of the
Act.
|
|
|
(d)
o
|
|
Investment
Company registered under Section 8 of the Investment Company Act of
1940.
|
|
|
(e)
o
|
|
An
investment adviser in accordance with Rule
13d-1(b)(1)(ii)(E).
|
|
|
(f)
o
|
|
An
employee benefit plan or endowment fund in accordance with Rule
13d-1(b)(1)(ii)(F);
|
|
|
(g)
o
|
|
A
parent holding company or control person in accordance with Rule
13d-1(b)(1)(ii)(G).
|
|
|
(h)
o
|
|
A
savings association as defined in Section 3(b) of the Federal Deposit
Insurance Act;
|
|
|
(i)
o
|
|
A
church plan that is excluded from the definition of an investment company
under Section 3(c)(14) of the Investment Company Act of
1940;
|
|
|
(j)
o
|
|
Group,
in accordance with Rule
13d-1(b)(1)(ii)(J).
|
|
|
Not
Applicable.
|
|
CUSIP No. 68230A 106
|
13G
|
Page 4
of 6
Pages
|
|
Item
4.
|
Ownership.
|
|
(a)
|
Amount
Beneficially Owned:
|
|
269,854
shares
|
|
(b)
|
Percent
of Class:
|
| 4.5% | |
|
(c)
|
Number
of shares as to which such person has:
|
|
(i)
sole
power to vote or to direct the vote:
|
|
|
269,854
shares
|
|
| (ii) shared power to vote or to direct the vote: | |
|
Not applicable
|
|
| (iii) sole power to dispose or direct the disposition of: | |
|
269,854
shares
|
|
| (iv) shared power to dispose or direct the disposition of: | |
|
Not applicable
|
|
Item
5.
|
Ownership of Five
Percent or Less of a Class.
|
|
|
If
this statement is being filed to report the fact that as of the date
hereof, the reporting person has ceased to be the beneficial owner of more
than 5% of the class of securities, check the following: x
|
|
Item
6.
|
Ownership of More than
Five Percent on Behalf of Another
Person.
|
|
|
Not
Applicable.
|
|
Item
7.
|
Identification and
Classification of the Subsidiary which Acquired the Security Being
Reported on By the Parent Holding Company or Control
Person.
|
|
|
Not
Applicable.
|
|
Item
8.
|
Identification and
Classification of Members of the
Group.
|
|
|
Not
Applicable.
|
|
CUSIP No. 68230A 106
|
13G
|
Page 5
of 6
Pages
|
|
Item
9.
|
Notice of Dissolution
of Group.
|
|
|
Not
Applicable.
|
|
Item
10.
|
Certification.
|
By
signing below I certify that, to the best of my knowledge and belief, the
securities referred to above were not acquired and are not held for the purpose
of or with the effect of changing or influencing the control of the issuer of
the securities and were not acquired and are not held in connection with or as a
participant in any transaction having that purpose or effect.
|
CUSIP No. 68230A 106
|
13G
|
Page 6
of 6
Pages
|
SIGNATURE
After reasonable inquiry and to the
best of my knowledge and belief, I certify that the information set forth in
this statement is true, complete and correct.
Date: August
5, 2009
By: /s/ Sylvain
Gendron
Sylvain
Gendron
Legal
Counsel